CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

DSP Healthcare Fund-Reg(G)

very highequitypharma & health care
39.62 0.10(0.26%) NAV as on 25 Nov 2025
0.07 % 1 M
-4.15 % 1 Y
21.11 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.91

As on 31 Oct, 2025
age-icon Age :

6 yrs 11 m

Since 30 11 ,2018
exit_load Exit Load :

0.5%

aum AUM :

3,143.91 Crs

lock_in Lock-in :

0.50% on or before 1M, Nil after 1M

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

6.75

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Chirag Dagli

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Others 2.09 %
Equity 97.91 %

TOP HOLDINGS

Cipla Ltd.8.55 %
Sun Pharmaceutical Industries...8.26 %
Cohance Lifesciences Ltd.7.11 %
Ipca Laboratories Ltd.6.86 %
Laurus Labs Ltd.6.73 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs68.95
Hospital & Healthcare Services12.35
Insurance1.53
Retailing0.47
Medical Equipment/Supplies/Accessories0.28
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)19.1621.8820.9132.7637.40
Net Assets(Rs Crores) (as on 31-Mar-2025) 1109.58 1291.46 1202.10 2352.32 3018.76
Scheme Returns(%)(Absolute)79.3413.12-4.6056.8613.41
B'mark Returns(%)(Absolute)NANANANANA
Category Rank26/7544/7561/7620/9017/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

DSP Healthcare Fund-Reg(G)Very HighEquity39.620.10(0.26%)NAV As on 25 Nov, 202530-Nov-2018Inception Date3,143.91AUM In Cr.-4.15%1Y21.11%3Y17.27%5Y21.76%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity287.600.59(0.21%)NAV As on 25 Nov, 202501-Aug-2005Inception Date1,124.88AUM In Cr.0.82%1Y23.63%3Y17.06%5Y17.96%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.680.08(0.28%)NAV As on 25 Nov, 202528-Dec-2015Inception Date1,324.90AUM In Cr.1.57%1Y21.76%3Y17.27%5Y11.97%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.